Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Economic Outcomes With the Use of SERI® Surgical Scaffold in Direct-to-implant Breast Reconstruction

NCT02033590 is registered in ClinicalTrials.gov with Sofregen Medical, Inc. as lead sponsor.

NCT NCT02033590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02033590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Economic Outcomes With the Use of SERI® Surgical Scaffold in Direct-to-implant Breast Reconstruction
Lead sponsor
Sofregen Medical, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
July 31, 2014
Completion date
August 31, 2014
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast reconstruction